3 ms·
A very large multiple? Not more than 3, and often much less. http://www.google.com/finance?q=NYSE:MRK&fstype=ii http://www.google.com/finance?q=NYSE:MRK&fstype
by yummyfajitas 17y ago
A very large multiple? Not more than 3, and often much less.
http://www.google.com/finance?q=NYSE:MRK&fstype=ii http://www.google.com/finance?q=NYSE:MRK&fstype=ii
http://www.google.com/finance?q=NYSE:JNJ&fstype=ii http://www.google.com/finance?q=NYSE:JNJ&fstype=ii
If you actually look at the numbers, you'll see that Big Pharma's operating expenses look much like Big Technology.
http://www.google.com/finance?q=NASDAQ:INTC&fstype=ii http://www.google.com/finance?q=NASDAQ:INTC&fstype=ii
http://www.google.com/finance?q=NASDAQ:GOOG&fstype=ii http://www.google.com/finance?q=NASDAQ:GOOG&fstype=ii
Note: my 1-3 multiple is actually just the ratio of "Selling/General/Admin. Expenses, Total" / "Research & Development". It's a gratuitous overestimate, since marketing is only a fraction of "Selling/General/Admin. Expenses". That category also includes things like producing drugs, accounting, delivery, etc. But I'm too lazy to look up a more detailed balance sheet.
[edit: I'm curious, why am I being downmodded? All I did was provide some facts.]
- jacquesm 17y agoVery large sums of money are spent per physician (up to 65 K / annum) to promote 'new' drugs with little or no benefit over the 'old' drugs (other than the extended patents). Also there are large expenditures that are not directly in the marketing budget but that you would normally classify as marketing, these include seminars, promotional meetings with prescribers, lobbying activities and so on. enjoy the read: http://www.nybooks.com/articles/17244 http://www.nybooks.com/articles/17244
- yummyfajitas 17y agoI wasn't looking at the marketing budget, but the "Selling/General/Admin. Expenses, Total" line item on the income sheet. All the items you describe (besides lobbying, which is an "Unusual expense") are included in my numbers, as I noted at the end of my post. Incidentally, I'm pretty sure your $65k/year is not typical. That would be the equivalent of having one salaried employee spending 100% of his time selling to a single doctor.
- jacquesm 17y agook, but that assumes that all research is 'real' research, plenty of that goes towards the extension of the life of existing drugs under new patents, which is the way to make money in that business. You're right, it wasn't 65,000, it was 'only' 61,000... and no, of course it is not spent by sending a full timer to a single physician, but the net outcome of expenditure / target market is $61,000. The figure came from this article: http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0050001 http://www.plosmedicine.org/article/info:doi/10.1371/journal...
- yummyfajitas 17y agoThat number is an upper bound, based on combining the largest estimates from several different sources. It's not clear that the numbers from different sources don't overlap, and the primary sources estimate only $29-35k/doctor in marketing spending. For comparison, Merck and Johnson and Johnson (the two drug companies I bothered to look up) spent $13k/doctor on R&D. Incidentally, one of the bigger items included in marketing is free samples (totalling $16,800 per doctor), expensed at retail price [1]. That's basically just a giveaway from the drug companies to people doctors feel are deserving (usually low income/uninsured patients). [1] The real cost is actually less, since the drug company would not necessarily get retail price if the drugs were not given away free.
- streety 17y agoAt the risk of beginning a meta-discussion I can only suggest because a person disagrees with you. Personally I found your contribution useful. It answered, at least roughly, a question I didn't have time to investigate myself: What ratio of marketing:R&D is considered acceptable?
- jacquesm 17y agore your edit: There are several interpretation to the 'down' button, one of them is 'I disagree with you', others are 'I don't like your facts', 'I don't like you' or 'you are wrong, but I can't be bothered to write it up' Which it is is always a guess.